載入...
Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients
BACKGROUND: We previously reported improved pathologic complete response (pCR) in a prospective phase II study using neoadjuvant bevacizumab in combination with chemotherapy compared to chemotherapy alone in breast cancer patients (41% vs. 25%, p = 0.0291). In this study, we queried germline single-...
Na minha lista:
發表在: | PLoS One |
---|---|
Main Authors: | , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Public Library of Science
2017
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5207665/ https://ncbi.nlm.nih.gov/pubmed/28045923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0168550 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|